Lyra Therapeutics Inc (LYRA)

Lyra Therapeutics Inc (LYRA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $337,227; returns 1 day +0.0%, 1 week +0.0%.

Lyra Therapeutics, Inc. is a clinical-stage biopharmaceutical company historically focused on developing novel integrated drug and delivery solutions for ear, nose, and throat (ENT) diseases, primarily chronic rhinosinusitis (CRS).

Groups LYRA belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Healthcare
• Medical Devices
• Life Sciences

LYRA financial model: income statement, cash flow and balance sheet